Established in 1982, Indian Infotech And Software Ltd. (IISL) is a non-banking financial company that provides loans to individuals and businesses at affordable interest rates. Besides offering financial assistance, IISL also invests in shares of companies with significant growth potential. The company actively supports both startups and established businesses dedicated to the "Make in India" initiative. For the latest updates, including theIndian Infotech and Software Ltd share priceand news, stay tuned to the company's developments.
Corporate Action | |
---|---|
Security Name | Indian Infotech And Software Ltd |
Issue Open/Close | February 6, 2024 - February 13, 2024 |
Record Date | January 29, 2024 |
Issue Size (Amount) | ₹41.83 Crores |
Issue Size (Shares) | ₹261,453,270 |
Right Issue Price | ₹1.6 per share |
Face Value | ₹1 Per Shares |
CMP | ₹2.52 |
Renunciation of Rights Entitlements | February 8, 2024 |
Terms of Payment | Full amount of Re. 1.60/- per share payable on application |
Entitlement | ₹13 Rights Equity Shares for every 50 fully paid-up Equity Shares held on Record Date |
Disclaimer: The Information compiled by CEBPL on a best efforts basis from information CEBPL received from third party vendors, believed to be reliable. The information may contain errors or omissions; and is subject to change without prior or additional notice. CEBPL provides corporate action information that may be of interest or relevance to CEBPL clients. This does not constitute a recommendation or advice by CEBPL, and CEBPL Clients may not rely upon it. CEBPL does not warrant that the information provided is accurate, timely, or complete. CEBPL Clients are urged to verify the information prior to using it in their investing and trading decisions, including, but not limited to, referral to independent financial news resources, company announcements, and regulatory filings or disclosures. "Investment in securities market are subject to market risks, read all the related documents carefully before investing". Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of retums to investors. Name of Compliance Officer-Prashant Salian Email Id-Prashant.salian@choiceindia.com Contact no. 022-67079999-Ext-2310. Name of Grievance Officer-Deepika Singhvi-Email Id-ig@choiceindia.com, Contact no. 022-67079999-Ext-834. www.choiceindia.com
Invest in best pharma mutual funds in India for 2020 with Investica. Explore our top recommended pharma mutual funds to start investing today.